Annual Total Liabilities
$42.54 M
+$18.53 M+77.14%
31 December 2023
Summary:
ProPhase Labs annual total liabilities is currently $42.54 million, with the most recent change of +$18.53 million (+77.14%) on 31 December 2023. During the last 3 years, it has risen by +$21.70 million (+104.06%). PRPH annual total liabilities is now at all-time high.PRPH Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$53.68 M
+$4.08 M+8.23%
30 September 2024
Summary:
ProPhase Labs quarterly total liabilities is currently $53.68 million, with the most recent change of +$4.08 million (+8.23%) on 30 September 2024. Over the past year, it has increased by +$18.40 million (+52.15%). PRPH quarterly total liabilities is now at all-time high.PRPH Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRPH Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +77.1% | +52.1% |
| 3 y3 years | +104.1% | +120.3% |
| 5 y5 years | +905.1% | +4366.1% |
PRPH Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +104.1% | at high | +123.5% |
| 5 y | 5 years | at high | +3979.0% | at high | +5046.9% |
| alltime | all time | at high | >+9999.0% | at high | +6070.3% |
ProPhase Labs Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $53.68 M(+8.2%) |
| June 2024 | - | $49.60 M(+9.8%) |
| Mar 2024 | - | $45.16 M(+6.2%) |
| Dec 2023 | $42.54 M(+77.1%) | $42.54 M(+20.6%) |
| Sept 2023 | - | $35.28 M(+10.9%) |
| June 2023 | - | $31.80 M(-10.3%) |
| Mar 2023 | - | $35.43 M(+47.5%) |
| Dec 2022 | $24.02 M(-21.7%) | $24.02 M(-19.8%) |
| Sept 2022 | - | $29.96 M(+0.6%) |
| June 2022 | - | $29.79 M(-10.3%) |
| Mar 2022 | - | $33.22 M(+8.3%) |
| Dec 2021 | $30.67 M(+47.1%) | $30.67 M(+25.9%) |
| Sept 2021 | - | $24.37 M(-14.8%) |
| June 2021 | - | $28.59 M(-12.8%) |
| Mar 2021 | - | $32.78 M(+57.2%) |
| Dec 2020 | $20.85 M(+1898.9%) | $20.85 M(+69.9%) |
| Sept 2020 | - | $12.27 M(+728.6%) |
| June 2020 | - | $1.48 M(+19.7%) |
| Mar 2020 | - | $1.24 M(+18.6%) |
| Dec 2019 | $1.04 M(-75.4%) | $1.04 M(-13.2%) |
| Sept 2019 | - | $1.20 M(+4.8%) |
| June 2019 | - | $1.15 M(+31.8%) |
| Mar 2019 | - | $870.00 K(-79.4%) |
| Dec 2018 | $4.23 M(+133.6%) | $4.23 M(+383.2%) |
| Sept 2018 | - | $876.00 K(-45.1%) |
| June 2018 | - | $1.59 M(+45.0%) |
| Mar 2018 | - | $1.10 M(-39.3%) |
| Dec 2017 | $1.81 M(-73.5%) | $1.81 M(-25.5%) |
| Sept 2017 | - | $2.43 M(-30.0%) |
| June 2017 | - | $3.47 M(-49.5%) |
| Mar 2017 | - | $6.87 M(+0.5%) |
| Dec 2016 | $6.84 M(+14.0%) | $6.84 M(+9.4%) |
| Sept 2016 | - | $6.25 M(+20.8%) |
| June 2016 | - | $5.18 M(-11.2%) |
| Mar 2016 | - | $5.83 M(-2.8%) |
| Dec 2015 | $6.00 M(+12.3%) | $6.00 M(+57.3%) |
| Sept 2015 | - | $3.81 M(+3.8%) |
| June 2015 | - | $3.68 M(-34.6%) |
| Mar 2015 | - | $5.62 M(+5.3%) |
| Dec 2014 | $5.34 M(+10.7%) | $5.34 M(-27.6%) |
| Sept 2014 | - | $7.38 M(+20.0%) |
| June 2014 | - | $6.15 M(+37.8%) |
| Mar 2014 | - | $4.46 M(-7.5%) |
| Dec 2013 | $4.82 M(-7.4%) | $4.82 M(-4.3%) |
| Sept 2013 | - | $5.04 M(+5.7%) |
| June 2013 | - | $4.77 M(+14.6%) |
| Mar 2013 | - | $4.16 M(-20.1%) |
| Dec 2012 | $5.21 M(-33.7%) | $5.21 M(-21.6%) |
| Sept 2012 | - | $6.64 M(+3.7%) |
| June 2012 | - | $6.40 M(-12.2%) |
| Mar 2012 | - | $7.30 M(-7.1%) |
| Dec 2011 | $7.85 M(-4.6%) | $7.85 M(+3.7%) |
| Sept 2011 | - | $7.57 M(+30.9%) |
| June 2011 | - | $5.79 M(-21.3%) |
| Mar 2011 | - | $7.36 M(-10.6%) |
| Dec 2010 | $8.23 M | $8.23 M(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $7.86 M(+23.6%) |
| June 2010 | - | $6.36 M(-3.1%) |
| Mar 2010 | - | $6.56 M(-9.7%) |
| Dec 2009 | $7.27 M(+10.3%) | $7.27 M(+23.0%) |
| Sept 2009 | - | $5.91 M(+6.9%) |
| June 2009 | - | $5.53 M(-8.8%) |
| Mar 2009 | - | $6.06 M(-8.1%) |
| Dec 2008 | $6.59 M(-35.7%) | $6.59 M(-3.6%) |
| Sept 2008 | - | $6.84 M(+1.3%) |
| June 2008 | - | $6.75 M(-5.3%) |
| Mar 2008 | - | $7.12 M(-30.6%) |
| Dec 2007 | $10.26 M(+10.9%) | $10.26 M(+10.3%) |
| Sept 2007 | - | $9.30 M(+2.2%) |
| June 2007 | - | $9.11 M(+9.3%) |
| Mar 2007 | - | $8.33 M(-9.9%) |
| Dec 2006 | $9.25 M(-12.7%) | $9.25 M(+25.5%) |
| Sept 2006 | - | $7.37 M(+26.7%) |
| June 2006 | - | $5.82 M(-26.4%) |
| Mar 2006 | - | $7.90 M(-25.5%) |
| Dec 2005 | $10.60 M(+10.7%) | $10.60 M(+24.8%) |
| Sept 2005 | - | $8.49 M(+33.9%) |
| June 2005 | - | $6.34 M(-26.6%) |
| Mar 2005 | - | $8.64 M(-9.7%) |
| Dec 2004 | $9.57 M(+74.6%) | $9.57 M(+154.7%) |
| Sept 2004 | - | $3.76 M(+16.0%) |
| June 2004 | - | $3.24 M(-28.1%) |
| Mar 2004 | - | $4.51 M(-17.8%) |
| Dec 2003 | $5.48 M(-15.8%) | $5.48 M(-14.7%) |
| Sept 2003 | - | $6.43 M(+18.3%) |
| June 2003 | - | $5.43 M(+3.4%) |
| Mar 2003 | - | $5.25 M(-19.3%) |
| Dec 2002 | $6.51 M(+83.2%) | $6.51 M(+62.1%) |
| Sept 2002 | - | $4.02 M(+33.1%) |
| June 2002 | - | $3.02 M(+5.1%) |
| Mar 2002 | - | $2.87 M(-19.3%) |
| Dec 2001 | $3.56 M(-26.7%) | $3.56 M(+2.7%) |
| Sept 2001 | - | $3.46 M(+19.7%) |
| June 2001 | - | $2.89 M(-3.5%) |
| Mar 2001 | - | $3.00 M(-38.2%) |
| Dec 2000 | $4.85 M(-31.4%) | $4.85 M(+18.5%) |
| Sept 2000 | - | $4.09 M(+36.6%) |
| June 2000 | - | $2.99 M(-33.1%) |
| Mar 2000 | - | $4.48 M(-36.7%) |
| Dec 1999 | $7.07 M(+76.8%) | $7.07 M(+152.5%) |
| Sept 1999 | - | $2.80 M(+55.6%) |
| June 1999 | - | $1.80 M(-47.1%) |
| Mar 1999 | - | $3.40 M(-15.0%) |
| Dec 1998 | $4.00 M(-50.6%) | $4.00 M(+11.1%) |
| Sept 1998 | - | $3.60 M(+89.5%) |
| June 1998 | - | $1.90 M(-52.5%) |
| Mar 1998 | - | $4.00 M(-50.6%) |
| Dec 1997 | $8.10 M(+3950.0%) | $8.10 M(+14.1%) |
| Sept 1997 | - | $7.10 M(+24.6%) |
| June 1997 | - | $5.70 M(-54.8%) |
| Mar 1997 | - | $12.60 M |
| Dec 1996 | $200.00 K | - |
FAQ
- What is ProPhase Labs annual total liabilities?
- What is the all time high annual total liabilities for ProPhase Labs?
- What is ProPhase Labs annual total liabilities year-on-year change?
- What is ProPhase Labs quarterly total liabilities?
- What is the all time high quarterly total liabilities for ProPhase Labs?
- What is ProPhase Labs quarterly total liabilities year-on-year change?
What is ProPhase Labs annual total liabilities?
The current annual total liabilities of PRPH is $42.54 M
What is the all time high annual total liabilities for ProPhase Labs?
ProPhase Labs all-time high annual total liabilities is $42.54 M
What is ProPhase Labs annual total liabilities year-on-year change?
Over the past year, PRPH annual total liabilities has changed by +$18.53 M (+77.14%)
What is ProPhase Labs quarterly total liabilities?
The current quarterly total liabilities of PRPH is $53.68 M
What is the all time high quarterly total liabilities for ProPhase Labs?
ProPhase Labs all-time high quarterly total liabilities is $53.68 M
What is ProPhase Labs quarterly total liabilities year-on-year change?
Over the past year, PRPH quarterly total liabilities has changed by +$18.40 M (+52.15%)